Sign in
4

Changes in Ownership

Elanco Animal Health Inc Filed Acc 0001415889-24-009140

Options or other derivatives

  • PRESIDENT, CEO AND DIRECTOR acquired 175.05 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Simmons Jeffrey N · PRESIDENT, CEO AND DIRECTOR

Table II: Derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-03-22 Grant or award : show line 1 in the form Deferred Stock Units +175.05 $15.82 $2,769 1,046.47 D
Loading xslF345X05/form4-03262024_090314.xml…